Press release
Pharma Cold Chain Distribution: Big Pharma, MHRA and leading logistics companies to meet in London this December
SMi Group reports (2016.11.28– London, UK): World Courier, Finnair, MHRA, IATA, Teva, GSK, J&J, Sanofi will meet in London this December at Cold Chain Distribution 2016.Over the last 24 months, we have witnessed market growth and new logistics hubs established around the globe by forwarders and distributors, in order to service and support a more round-the-clock global network for pharmaceutical product supply. Nonetheless, challenges remain with the increasingly fragile biologics product and tightened GDP regulations.
Just a fortnight remains until the SMi Group opens their doors to host the 11th annual conference on Cold Chain Distribution. This year’s event will bring over 120 attendees from all over the world including senior representatives from big pharma, biotech and service providers with responsibilities in supply chain, cold chain, logistics, distribution, packaging, operations, production, manufacturing, QA and QC from Austria, Belgium, Denmark, Finland, France, Ireland, Israel, Netherlands, Switzerland, United Kingdom and other countries to keep abreast of cold chain distribution developments!
Further information available at www.coldchain-distribution.com/OpenPR
Cold Chain Distribution 2016 speaker line up includes key decision makers and leading pharma cold chain experts representing MHRA, Danish Medicines Agency, IATA, NHS Blood & Transplant, Sanofi-Aventis, Johnson & Johnson, GlaxoSmithKline, GSK Biologicals, Teva Pharmaceutical, The Grimsby Institute, World Courier, Finnair Cargo, PCI Pharma Services, Cell and Gene Therapy Catapult, Modalis, Exelsius, Vertex International Ltd and more.
The complete 2-day event programme including all speakers and their topics can be viewed at www.coldchain-distribution.com/OpenPR
“The aviation industry has made improvements for cold chain distribution, despite improvements there are still challenges that remain unanswered. It's time to discuss the next trends of cold chain distribution as air cargo." Frederik Wildtgrube, Head of Global Sales, Finnair.
Confirmed attendees include key decision makers from Accord Healthcare, Actelion Pharmaceuticals UK, Al Medicines, Alliance Healthcare, Almac Group, Avery Dennison Materials Europe B.V., BIOTRANS SA, Birmingham Children’s Hospital, Bristol-Myers Squibb, Brussels Airport Company, Business Unit Pharma, Catapult Cell & Gene Therapy, Cell Therapy Catapult, Copenhagen Capacity, Copenhagen Univeristy, Danish Medicines Agency, Day Lewis Plc, DBS Ltd, Eberspaecher, Eli Lilly Italia SpA, Envirotainer, Exelsius, Finnair Cargo, Genzyme Pharmaceuticals, GlaxoSmithKline, GSK Biologicals, GW Pharmaceuticals, IATA, Janssen Pharmaceutica N.V., JB360solutions, Johnson & Johnson, Kings College London, Kyowa Kirin International plc., Lysogene, MHRA, Modalis, MSD, NHS Blood & Transplant, Norgine Ltd, Novartis Business Services, Panalpina, PCI Pharma Services, Pfizer Group, Porton Biopharma, ReNeuron, Roche Pharmaceuticals, Sanofi-Aventis, Seer Pharma, Shionogi Ltd, Shire/Global Logistics Validation, Softbox Systems Ltd, Teva Pharmaceutical, The Doctors Laboratory Ltd, The Grimsby Institute, va-Q-tec AG, Vertex Pharmaceuticals (Europe), Wockhardt UK, World Courier, Yourway Transport and many more!
“We consider SMi’s Cold Chain Distribution conference as the industry-leading event in the UK which has always attracted a good mix and level of speakers and delegates, including both our customers and suppliers, who are all key opinion leaders in their respective fields. It serves as a good platform for us to engage with attendees, share best practices and challenge our theories on the future of temperature controlled distribution. As cold chain distribution is our core business, it’s imperative that we continue to evolve in accordance with the needs of our customers.” David Spillett, Key Account Director, World Courier.
Further information available at www.coldchain-distribution.com/OpenPR
Cold Chain Distribution 2016 offers to its attendees a fantastic networking opportunity with the leading experts in the industry at a drinks reception on day one followed by a Gala Dinner (invitation only) hosted by World Courier.
We are proud to be sponsored by the leading service providers including: World Courier (Lead Sponsor), Berlinger & Co. AG, Eberspächer, ELPRO, Emball'iso, Finnair Cargo, NEFTAG, Peli BioThermal, Sensitech, SMO Group, Testo Limited, Topa Thermal, va-Q-tech and Yourway Transport.
11th Annual Cold Chain Distribution Conference and Exhibition
Park Plaza Victoria, London, UK
12th-13th December, 2016
www.coldchain-distribution.com/OpenPR
Sponsors/Exhibitors: Contact Alia Malick on amalick@smi-online.co.uk
Delegates/Groups: Contact Fateja Begum on fbegum@smi-online.co.uk
Media Enquiries: Contact Julia Rotar on jrotar@smi-online.co.uk
-------------------------------END OF PRESS-RELEASE------------------------------
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
1 Westminster Bridge Road, London
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharma Cold Chain Distribution: Big Pharma, MHRA and leading logistics companies to meet in London this December here
News-ID: 388134 • Views: …
More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK.
The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines.
Darren Green, Director of Computational Chemistry at GSK will be chairing at…

Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety.
SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA.
The 2022 Conference theme is…

SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022.
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering…

Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.
Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022.
This event will convene on February 9th – 10th 2022,…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…